Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
This approach uses the pharmaceutical product for dose titration when medical support is most critical, then transitions to lower-cost options for maintenance
doi: 10.3389/fnagi.2019.00088 98 DeaconCFJohnsenAHHolstJJ
Until retatrutide launches and any cash-pay program comes with it, your options for GLP-1 treatment are: Brand drugs at list price (currently ,000 to ,400 per month) Manufacturer self-pay programs like Lilly Direct (Zepbound vials at to per month for cash-pay patients) Legitimate compounded semaglutide or tirzepatide through US-licensed pharmacies (often to per month) TrimRx provides the third option
The research indicates that you shouldnt need to cancel for medical reasons, but if you did, there is a partial refund process, however convoluted
External appeals of GLP-1 denials have a higher overturn rate than internal appeals, partly because IROs apply clinical evidence standards rather than plan-specific cost criteria
US$ 20.00
US$ 20.48
US$ 28.21
US$ 21.84
US$ 25.13
US$ 26.43
US$ 22.87
US$ 25.88
US$ 23.28
US$ 26.02
US$ 24.25
US$ 29.32
